Health Canada approves Abbott’s Absorb Bioresorbable Stent
Abbott announced that Health Canada has approved the company's Absorb bioresorbable heart stent, making the first-of-its-kind medical device commercially available to treat people in...
Sandoz Biosimilar Etanercept Recommended By Fda For Approval To Treat Multiple Inflammatory Diseases
Sandoz, a Novartis division and leader in biosimilars, announced today that the US FDA Advisory Committee recommended approval of its proposed biosimilar etanercept.
The...
U.S. FDA Grants Priority Review to Janssen’s New Drug Application for Chewable Mebendazole Tablets
Janssen Pharmaceuticals, Inc one of the Janssen Pharmaceutical Companies of Johnson & Johnson (Janssen), announced today that the U.S. Food and Drug Administration (FDA)...
Lilly And Boehringer Ingelheim Announce Clinical Trial Collaboration In Metastatic Breast Cancer
Eli Lilly and Company and Boehringer Ingelheim announced a new collaboration on a Phase 1b study that will evaluate the safety and tolerability of...
Bayer and X-Chem Expand Drug Discovery Collaboration to Discover Novel Medicines
Bayer and X-Chem, Inc focused on applying its innovative drug discovery capabilities to the generation of novel small molecule therapeutics, have entered into an...
AbbVie Receives U.S. FDA Rare Pediatric Disease Designation for Investigational ABT
AbbVie a global biopharmaceutical company, announced that the U.S. FDA granted Rare Pediatric Disease Designation for ABT-414, an investigational antibody drug conjugate (ADC) targeting...
EC Grants Marketing Authorization for Gilead’s Epclusa for the Treatment of All Genotypes of Chronic Hepatitis C
Gilead Sciences, Inc announced that the European Commission has granted marketing authorization for Epclusa® (sofosbuvir 400 mg/velpatasvir 100 mg), the first pan-genotypic, single tablet...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...